Dalm VASH - Search Results

1

Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.

van Leeuwen LPM, Grobben M, GeurtsvanKessel CH, Ellerbroek PM, de Bree GJ, Potjewijd J, Rutgers A, Jolink H, van de Veerdonk FL, van Gils MJ, de Vries RD, Dalm VASH; VACOPID Research Group. van Leeuwen LPM, et al. Among authors: dalm vash. Front Immunol. 2024 Apr 18;15:1390022. doi: 10.3389/fimmu.2024.1390022. eCollection 2024. Front Immunol. 2024. PMID: 38698851 Free PMC article.

2

Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells.

Dalm VA, van Hagen PM, van Koetsveld PM, Achilefu S, Houtsmuller AB, Pols DH, van der Lely AJ, Lamberts SW, Hofland LJ. Dalm VA, et al. Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E344-53. doi: 10.1152/ajpendo.00048.2003. Epub 2003 Apr 8. Am J Physiol Endocrinol Metab. 2003. PMID: 12684217 Free article.

3

The role of octreotide scintigraphy in rheumatoid arthritis and sarcoidosis.

Dalm VA, van Hagen PM, Krenning EP. Dalm VA, et al. Q J Nucl Med. 2003 Dec;47(4):270-8. Q J Nucl Med. 2003. PMID: 14973419 Free article. Review.

4

Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets.

Lichtenauer-Kaligis EG, Dalm VA, Oomen SP, Mooij DM, van Hagen PM, Lamberts SW, Hofland LJ. Lichtenauer-Kaligis EG, et al. Eur J Endocrinol. 2004 Apr;150(4):565-77. doi: 10.1530/eje.0.1500565. Eur J Endocrinol. 2004. PMID: 15080788

5

Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues.

Dalm VA, Van Hagen PM, de Krijger RR, Kros JM, Van Koetsveld PM, Van Der Lely AJ, Lamberts SW, Hofland LJ. Dalm VA, et al. Clin Endocrinol (Oxf). 2004 May;60(5):625-9. doi: 10.1111/j.1365-2265.2004.02024.x. Clin Endocrinol (Oxf). 2004. PMID: 15104567

6

The role of somatostatin and somatostatin analogs in the pathophysiology of the human immune system.

Dalm VA, Hofland LJ, Ferone D, Croxen R, Lamberts SW, van Hagen PM. Dalm VA, et al. J Endocrinol Invest. 2003;26(8 Suppl):94-102. J Endocrinol Invest. 2003. PMID: 15233222 Review. No abstract available.

7

Efficacy of lenalidomide in refractory lupus pernio.

Dalm VA, van Hagen PM. Dalm VA, et al. JAMA Dermatol. 2013 Apr;149(4):493-4. doi: 10.1001/jamadermatol.2013.1313. JAMA Dermatol. 2013. PMID: 23715134 No abstract available.

8

Everything you need to know about distal renal tubular acidosis in autoimmune disease.

Both T, Zietse R, Hoorn EJ, van Hagen PM, Dalm VA, van Laar JA, van Daele PL. Both T, et al. Rheumatol Int. 2014 Aug;34(8):1037-45. doi: 10.1007/s00296-014-2993-3. Epub 2014 Mar 29. Rheumatol Int. 2014. PMID: 24682397 Free PMC article. Review.

9

The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.

Virakul S, Dalm VA, Paridaens D, van den Bosch WA, Hirankarn N, van Hagen PM, Dik WA. Virakul S, et al. Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1101-9. doi: 10.1007/s00417-014-2674-7. Epub 2014 May 30. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24874745

10

Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome.

Both T, Hoorn EJ, Zietse R, van Laar JA, Dalm VA, Brkic Z, Versnel MA, van Hagen PM, van Daele PL. Both T, et al. Rheumatology (Oxford). 2015 May;54(5):933-9. doi: 10.1093/rheumatology/keu401. Epub 2014 Oct 29. Rheumatology (Oxford). 2015. PMID: 25354755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters